Accretion Nutraveda Ltd. (ANL)
BSE
Closed
Aug 25, 2026
Day's Range
288.0552 wk Range
150.10Overview - ANL - Accretion Nutraveda Ltd.
Key Statistics
Valuation
Enterprise Value
2.01B
P/E (Trailing)
‪33.47‬
Price / Sales (TTM)
‪6.74‬
Price / Book
‪6.38‬
EV / EBITDA
‪29.17‬
Profitability
Profit Margin
‪15.07%‬
Operating Margin
‪17.98%‬
Return on Assets
‪15.88%‬
Return on Equity
‪25.01%‬
Ownership
Shares Outstanding
7.24M
Float
1.84M
Held by Insiders
‪82.87%‬
Held by Institutions
‪0.00%‬
Price stats
50-Day Avg
‪273.48‬
200-Day Avg
‪238.88‬
Dividends
Payout Ratio
‪0.00%‬
Shariah Compliance
Report Date: Feb 18, 2025
Screened by Zoya using the AAOIFI methodology.
Peers - ANL - Accretion Nutraveda Ltd.
Peer Comparison
Compared with companies in Drug Manufacturers - Specialty & Generic listed on BSE.
Profile Summary - ANL - Accretion Nutraveda Ltd.
About
Accretion Nutraveda Ltd. is a healthcare-focused Contract Development and Manufacturing Organization (CDMO) specializing in Ayurvedic, nutraceutical, and pharmaceutical products. Founded on March 16, 2021, in Ahmedabad, Gujarat, India, the company manufactures a diverse range of dosage forms, including tablets,…
The information on this page is provided for general informational purposes only and is not investment advice.
Market data provided by Twelve Data. Shariah compliance data provided by Zoya. Charting by TradingView.
Last updated:
